VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
QTRXQuanterix Corporation
$3.39$159M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

QTRX logoQuanterix Corporation(QTRX)Earnings, Financials & Key Ratios

QTRX•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryDevice suppliers, distribution, and services
AboutQuanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.Show more
  • Revenue$139M+2.4%
  • EBITDA-$91M-105.4%
  • Net Income-$107M-178.1%
  • EPS (Diluted)-2.51-151.0%
  • Gross Margin46.67%-22.1%
  • EBITDA Margin-65.55%-100.6%
  • Operating Margin-79.2%-103.9%
  • Net Margin-77.28%-171.6%
  • ROE-34.25%-202.2%

QTRX Key Insights

Quanterix Corporation (QTRX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Trading at only 0.5x book value

✗Weaknesses

  • ✗Profits declining 27.7% over 5 years
  • ✗Weak Piotroski F-Score: 2/9
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 15 (bottom 15%)
  • ✗Shares diluted 11.1% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when QTRX posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

QTRX Price & Volume

Quanterix Corporation (QTRX) stock price & volume — 10-year historical chart

Loading chart...

QTRX Growth Metrics

Quanterix Corporation (QTRX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years27.53%
5 Years9.93%
3 Years9.53%
TTM8.18%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-117.64%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-90.32%

Return on Capital

10 Years-42.82%
5 Years-19.32%
3 Years-18.86%
Last Year-31%

QTRX Recent Earnings

Quanterix Corporation (QTRX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 6, 2026
Metric
Actual
Est
EPS
$0.39-25.8%
$0.31
Rev
$36M-1.2%
$37M
Q2 2026
Mar 2, 2026
Metric
Actual
Est
EPS
$0.38-40.7%
$0.27
Rev
$44M+14.8%
$38M
Q4 2025
Nov 10, 2025
Metric
Actual
Est
EPS
$0.36-56.5%
$0.23
Rev
$40M+5.8%
$38M
Q3 2025
Aug 7, 2025
Metric
Actual
Est
EPS
$0.47-14.6%
$0.41
Rev
$24M-36.5%
$39M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 6, 2026
$0.39vs $0.31-25.8%
$36Mvs $37M-1.2%
Q2 2026Mar 2, 2026
$0.38vs $0.27-40.7%
$44Mvs $38M+14.8%
Q4 2025Nov 10, 2025
$0.36vs $0.23-56.5%
$40Mvs $38M+5.8%
Q3 2025Aug 7, 2025
$0.47vs $0.41-14.6%
$24Mvs $39M-36.5%
Based on last 12 quarters of dataView full earnings history →

QTRX Peer Comparison

Quanterix Corporation (QTRX) competitors in Device suppliers, distribution, and services — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
SEER logoSEERSeer, Inc.Direct Competitor95.67M1.74-1.3615.57%-468.74%-26.58%0.09
CDNA logoCDNACareDx, IncDirect Competitor1.35B26.18-65.4513.79%-1.98%-2.61%0.06
NTRA logoNTRANatera, Inc.Direct Competitor33.14B231.41-152.2435.9%-9.05%-15.13%0.13
PRAX logoPRAXPraxis Precision Medicines, Inc.Direct Competitor8.15B282.31-20.94-100%-43.02%0.00
BIO logoBIOBio-Rad Laboratories, Inc.Product Competitor7.63B282.4410.130.65%6.52%2.4%0.21
MESO logoMESOMesoblast LimitedProduct Competitor1.85B14.37-17.11191.39%-5.94%-17.1%0.21
ABCL logoABCLAbCellera Biologics Inc.Product Competitor1.69B5.53-11.29160.56%-181.75%-14.22%0.13
FLGT logoFLGTFulgent Genetics, Inc.Product Competitor535.45M18.00-9.1413.83%-18.75%-5.42%0.00

Compare QTRX vs Peers

Quanterix Corporation (QTRX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs SEER

Most directly comparable listed peer for QTRX.

Scale Benchmark

vs TMO

Larger-name benchmark to compare QTRX against a more recognizable public peer.

Peer Set

Compare Top 5

vs SEER, CDNA, NTRA, PRAX

QTRX Income Statement

Quanterix Corporation (QTRX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
22.87M37.63M56.73M86.38M110.56M105.52M121.14M135.44M138.65M144.87M
Revenue Growth %
30.08%64.52%50.76%52.25%27.99%-4.55%14.8%11.8%2.38%8.18%
Cost of Goods Sold
12.89M19.65M29.9M38.2M45.78M60.16M48.14M54.32M73.94M80.87M
COGS % of Revenue
56.34%52.21%52.7%44.22%41.41%57.01%39.74%40.11%53.33%-
Gross Profit
9.99M▲ 0%
17.98M▲ 80.1%
26.84M▲ 49.2%
48.18M▲ 79.5%
64.77M▲ 34.4%
45.36M▼ 30.0%
73M▲ 60.9%
81.12M▲ 11.1%
64.72M▼ 20.2%
63.93M▲ 0%
Gross Margin %
43.66%47.79%47.3%55.78%58.59%42.99%60.26%59.89%46.67%44.13%
Gross Profit Growth %
28.9%80.07%49.22%79.54%34.43%-29.97%60.91%11.13%-20.22%-
Operating Expenses
35.99M49.07M68.44M79.77M121.29M149.63M118.99M133.74M174.53M183.75M
OpEx % of Revenue
157.35%130.39%120.63%92.35%109.71%141.8%98.22%98.74%125.88%-
Selling, General & Admin
19.69M33.78M52.25M59.59M92.91M91.85M92.82M104.64M138.85M135.9M
SG&A % of Revenue
86.07%89.75%92.09%68.99%84.04%87.04%76.63%77.26%100.14%-
Research & Development
16.3M15.29M16.19M20.17M28.38M26.81M26.06M31.08M35.92M33.21M
R&D % of Revenue
71.28%40.64%28.54%23.36%25.67%25.41%21.52%22.95%25.91%-
Other Operating Expenses
-62K-7K00030.97M99K-1.99M-243K1.9M
Operating Income
-26M▲ 0%
-31.55M▼ 21.3%
-41.6M▼ 31.9%
-31.58M▲ 24.1%
-56.52M▼ 79.0%
-104.26M▼ 84.5%
-45.99M▲ 55.9%
-52.62M▼ 14.4%
-109.81M▼ 108.7%
-139.66M▲ 0%
Operating Margin %
-113.69%-83.84%-73.32%-36.57%-51.12%-98.81%-37.97%-38.85%-79.2%-96.4%
Operating Income Growth %
-19.78%-21.32%-31.85%24.08%-78.95%-84.47%55.89%-14.41%-108.71%-
EBITDA
-25.52M-30.2M-38.59M-27.27M-51.64M-98.86M-37.7M-44.26M-90.89M-124.98M
EBITDA Margin %
-111.58%-80.25%-68.02%-31.57%-46.71%-93.68%-31.12%-32.68%-65.55%-86.27%
EBITDA Growth %
-20.01%-18.32%-27.79%29.33%-89.36%-91.43%61.86%-17.4%-105.35%-128.04%
D&A (Non-Cash Add-back)
482K1.35M3.01M4.31M4.88M5.41M8.29M8.36M18.93M14.68M
EBIT
-26.07M-31.55M-41.6M-31.58M-56.52M-73.3M-44.66M-52.62M-109.81M-89.3M
Net Interest Income
-951K46K627K-273K-403K5.13M15.84M14.65M8.57M5.3M
Interest Income
1K46K627K005.13M15.84M14.65M8.57M6.19M
Interest Expense
952K00273K403K00000
Other Income/Expense
-1.01M39K617K-322K937K4.85M18.36M14.52M-2.46M9.44M
Pretax Income
-27.02M▲ 0%
-31.05M▼ 14.9%
-40.98M▼ 32.0%
-31.91M▲ 22.1%
-55.58M▼ 74.2%
-99.41M▼ 78.8%
-27.64M▲ 72.2%
-38.1M▼ 37.9%
-112.27M▼ 194.7%
-106.4M▲ 0%
Pretax Margin %
-118.12%-82.5%-72.24%-36.94%-50.28%-94.21%-22.81%-28.13%-80.97%-73.45%
Income Tax
025K-187K-376K-36K164K719K434K-5.12M-2.21M
Effective Tax Rate %
0%-0.08%0.46%1.18%0.06%-0.16%-2.6%-1.14%4.56%2.08%
Net Income
-27.02M▲ 0%
-31.05M▼ 14.9%
-40.8M▼ 31.4%
-31.53M▲ 22.7%
-55.55M▼ 76.2%
-99.57M▼ 79.3%
-28.35M▲ 71.5%
-38.53M▼ 35.9%
-107.15M▼ 178.1%
-104.19M▲ 0%
Net Margin %
-118.12%-82.5%-71.91%-36.5%-50.24%-94.36%-23.41%-28.45%-77.28%-71.92%
Net Income Growth %
-16.6%-14.9%-31.41%22.71%-76.18%-79.26%71.52%-35.89%-178.09%-117.64%
Net Income (Continuing)
-27.02M-31.54M-40.8M-31.53M-55.55M-99.57M-28.35M-38.53M-107.15M-104.19M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
-1.24▲ 0%
-1.39▼ 12.1%
-1.63▼ 17.3%
-1.07▲ 34.4%
-1.60▼ 49.5%
-2.61▼ 63.1%
-0.86▲ 67.0%
-1.00▼ 16.3%
-2.51▼ 151.0%
-2.22▲ 0%
EPS Growth %
13.29%-12.1%-17.27%34.36%-49.53%-63.13%67.05%-16.28%-151%-90.32%
EPS (Basic)
-1.24-1.41-1.63-1.07-1.60-2.61-0.86-1.00-2.51-
Diluted Shares Outstanding
21.71M22.37M25.09M29.59M36M36.99M37.59M38.37M42.64M46.98M
Basic Shares Outstanding
21.71M21.99M25.09M29.59M36M36.99M37.59M38.37M42.64M46.98M
Dividend Payout Ratio
----------

QTRX Balance Sheet

Quanterix Corporation (QTRX) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
89.25M60.51M132.66M219.6M448.95M381.52M382.1M363.59M212.26M185.72M
Cash & Short-Term Investments
79.68M45.43M109.16M181.58M396.46M338.74M321.32M289.12M118.23M99.27M
Cash Only
79.68M45.43M109.16M181.58M396.46M338.74M174.42M56.71M29.84M36.18M
Short-Term Investments
000000146.9M232.41M88.39M63.08M
Accounts Receivable
5.6M6.79M10.91M17.18M23.79M19.02M25.41M32.14M29.97M26.78M
Days Sales Outstanding
89.3465.8870.1672.6178.5365.7876.5786.6278.971.38
Inventory
3.57M5.96M10.46M14.86M22.19M16.96M26.12M32.77M54.76M50.96M
Days Inventory Outstanding
101.14110.76127.73141.97176.9102.92198.05220.24270.34215.32
Other Current Assets
400K2.33M006.51M6.8M9.23M9.56M9.29M8.72M
Total Non-Current Assets
2.53M7.12M37.29M51.44M57.56M52.06M46.47M42.94M206.51M180.95M
Property, Plant & Equipment
1.87M2.92M12.05M25.91M29.45M41.03M36.18M33.49M40.34M37.23M
Fixed Asset Turnover
12.21x12.87x4.71x3.33x3.75x2.57x3.35x4.04x3.44x3.77x
Goodwill
01.31M9.35M10.46M9.63M00026.38M26.71M
Intangible Assets
02.35M14.31M13.72M10.53M7.52M6.03M4.03M131.79M109.16M
Long-Term Investments
653K1M1.03M02.58M2.6M0003.44M
Other Non-Current Assets
-1K536K-1.67M1.36M378K-6.86M4.26M5.42M8.01M7.85M
Total Assets
91.78M▲ 0%
67.63M▼ 26.3%
169.95M▲ 151.3%
271.05M▲ 59.5%
506.51M▲ 86.9%
433.58M▼ 14.4%
428.57M▼ 1.2%
406.53M▼ 5.1%
418.77M▲ 3.0%
366.67M▲ 0%
Asset Turnover
0.25x0.56x0.33x0.32x0.22x0.24x0.28x0.33x0.33x0.36x
Asset Growth %
147.27%-26.31%151.3%59.48%86.87%-14.4%-1.16%-5.14%3.01%-5.14%
Total Current Liabilities
19.71M17.66M19.83M39.8M36.98M31.35M38.98M42.01M74.76M49.91M
Accounts Payable
3.55M5.11M5.78M6.8M9.21M3.84M5.05M6.95M13.57M8.66M
Days Payables Outstanding
100.694.9370.5364.9773.4223.2738.2746.7266.9847.37
Short-Term Debt
5.04M075K7.67M1.43M2.69M0007.93M
Deferred Revenue (Current)
4.94M5.44M4.7M5.42M6.36M8.64M9.47M8.83M20.73M66.26M
Other Current Liabilities
3.56M3.13M2.71M13.83M6.73M5.15M14.17M12.62M21.85M18.13M
Current Ratio
4.53x3.43x6.69x5.52x12.14x12.17x9.80x8.66x2.84x3.72x
Quick Ratio
4.35x3.09x6.16x5.14x11.54x11.63x9.13x7.88x2.11x2.70x
Cash Conversion Cycle
89.8881.7127.37149.61182.02145.43236.35260.14282.26239.32
Total Non-Current Liabilities
6.2M8.41M21.46M25.12M28.59M44.3M39.63M34.49M48.27M34.63M
Long-Term Debt
4.35M7.62M7.59M00000027.4M
Capital Lease Obligations
00021.89M20.46M41.42M37.22M32.62M29.32M91.41M
Deferred Tax Liabilities
002.83M2.65M7.02M9.24M1.18M800K8.1M8.1M
Other Non-Current Liabilities
144K278K10.58M00-7.77M005.02M7.22M
Total Liabilities
25.91M26.07M41.29M64.92M65.56M75.65M78.61M76.5M123.04M84.53M
Total Debt
9.38M7.62M7.66M30.8M21.89M44.1M41.46M37.37M37.24M35.34M
Net Debt
-70.3M-37.81M-101.49M-150.79M-374.57M-294.64M-132.96M-19.34M7.4M-846K
Debt / Equity
0.14x0.18x0.06x0.15x0.05x0.12x0.12x0.11x0.13x0.13x
Debt / EBITDA
----------0.28x
Net Debt / EBITDA
---------0.01x
Interest Coverage
-27.38x---115.69x-140.25x-----
Total Equity
65.87M▲ 0%
41.56M▼ 36.9%
128.66M▲ 209.6%
206.13M▲ 60.2%
440.95M▲ 113.9%
357.93M▼ 18.8%
349.96M▼ 2.2%
330.04M▼ 5.7%
295.73M▼ 10.4%
282.14M▲ 0%
Equity Growth %
388.77%-36.91%209.6%60.21%113.92%-18.83%-2.23%-5.69%-10.4%-41.56%
Book Value per Share
3.031.865.136.9712.259.689.318.606.946.01
Total Shareholders' Equity
65.87M41.56M128.66M206.13M440.95M357.93M349.96M330.04M295.73M282.14M
Common Stock
22K22K28K32K37K37K38K39K47K47K
Retained Earnings
-144.35M-175.89M-216.24M-247.77M-305.46M-403.2M-431.55M-470.08M-577.23M-594.77M
Treasury Stock
0000000000
Accumulated OCI
-2.42M-3.02M-153K2.43M441K-2.54M-1.67M-3.08M-723K-1.01M
Minority Interest
0000000000

QTRX Cash Flow Statement

Quanterix Corporation (QTRX) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-22.11M-28.72M-26.19M-23.36M-47.91M-48.27M-18.9M-35.16M-77.24M-81.45M
Operating CF Margin %
-96.64%-76.32%-46.16%-27.05%-43.33%-45.75%-15.6%-25.96%-55.7%-
Operating CF Growth %
-24.6%-29.92%8.82%10.78%-105.04%-0.76%60.84%-86.03%-119.65%-944.59%
Net Income
-27.02M-31.54M-40.8M-31.53M-57.69M-96.7M-32.33M-38.53M-107.15M-104.19M
Depreciation & Amortization
482K1.35M3.01M4.31M4.85M5.35M8.38M8.36M18.93M22.58M
Stock-Based Compensation
2.17M4.88M6.39M10.1M15.97M15.44M16.76M19.99M20.72M9.79M
Deferred Taxes
90K-14K140K416K801K-226K00-5.87M-19.84M
Other Non-Cash Items
238K170K700K808K340K25.79M92K-6.19M-1.51M27.95M
Working Capital Changes
1.94M-3.58M4.37M-7.47M-12.19M2.07M-11.8M-18.79M-2.35M-17.74M
Change in Receivables
-1.68M-983K-3.37M-6.24M-6.85M5.16M-6.7M-7.7M10.61M9M
Change in Inventory
-2.04M-1.6M-3.45M-5.12M-8.09M5.39M-5.36M-6.68M4.03M5.17M
Change in Payables
1M1.32M621K649K2.41M-5.36M1.19M723K-528K-5.77M
Cash from Investing
-1.13M-5.45M-25.38M-626K-6.34M-11.21M-148.4M-82.27M50.23M42.73M
Capital Expenditures
-1.13M-1.52M-10.85M-3.93M-13.62M-11.73M-3.79M-3.37M-2.61M-1.44M
CapEx % of Revenue
4.95%4.03%19.12%4.55%12.32%11.11%3.13%2.49%1.88%1%
Acquisitions
0-3.8M-14.53M00000-93.23M-84.23M
Investments
----------
Other Investing
015K03.3M7.28M520K0000
Cash from Financing
73.25M-78K116.2M96.24M270.8M2.31M2.69M456K-708K-1.57M
Debt Issued (Net)
-980K-1.93M-50K-75K-7.74M0000-83K
Equity Issued (Net)
74M-20K112.55M91.4M269.72M2.31M2.89M3.07M738K-19K
Dividends Paid
0000000000
Share Repurchases
0-20K0000000-429K
Other Financing
231K1.87M3.7M4.91M8.81M0-198K-2.61M-1.45M-1.47M
Net Change in Cash
50.01M▲ 0%
-34.25M▼ 168.5%
64.75M▲ 289.0%
72.4M▲ 11.8%
216.46M▲ 199.0%
-57.7M▼ 126.7%
-164.31M▼ 184.7%
-117.71M▲ 28.4%
-26.14M▲ 77.8%
-40.32M▲ 0%
Free Cash Flow
-23.24M▲ 0%
-30.24M▼ 30.1%
-37.03M▼ 22.5%
-27.3M▲ 26.3%
-61.52M▼ 125.4%
-60M▲ 2.5%
-22.69M▲ 62.2%
-38.53M▼ 69.8%
-79.85M▼ 107.2%
-82.9M▲ 0%
FCF Margin %
-101.59%-80.35%-65.28%-31.6%-55.65%-56.86%-18.73%-28.45%-57.59%-57.22%
FCF Growth %
-27.21%-30.13%-22.47%26.3%-125.4%2.48%62.18%-69.82%-107.23%-151.16%
FCF per Share
-1.07-1.35-1.48-0.92-1.71-1.62-0.60-1.00-1.87-1.76
FCF Conversion (FCF/Net Income)
0.82x0.93x0.64x0.74x0.86x0.48x0.67x0.91x0.72x0.80x
Interest Paid
0000000000
Taxes Paid
00000684K808K875K0385K

QTRX Key Ratios

Quanterix Corporation (QTRX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-68.11%-57.8%-47.94%-18.84%-17.17%-24.93%-8.01%-11.33%-34.25%-35.17%
Return on Invested Capital (ROIC)
--631%-201.84%-57.42%-69.65%-120.61%-24.61%-14.96%-26.84%-38.23%
Gross Margin
43.66%47.79%47.3%55.78%58.59%42.99%60.26%59.89%46.67%44.13%
Net Margin
-118.12%-82.5%-71.91%-36.5%-50.24%-94.36%-23.41%-28.45%-77.28%-71.92%
Debt / Equity
0.14x0.18x0.06x0.15x0.05x0.12x0.12x0.11x0.13x0.13x
Interest Coverage
-27.38x---115.69x-140.25x-----
FCF Conversion
0.82x0.93x0.64x0.74x0.86x0.48x0.67x0.91x0.72x0.80x
Revenue Growth
30.08%64.52%50.76%52.25%27.99%-4.55%14.8%11.8%2.38%8.18%
Related:QTRX Dividend History·QTRX Revenue History·QTRX Price History·QTRX P/E History·QTRX Financial Ratios·QTRX Institutional Holders

QTRX SEC Filings & Documents

Quanterix Corporation (QTRX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 6, 2026·SEC

Material company update

Mar 2, 2026·SEC

Material company update

Jan 8, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 2, 2026·SEC

FY 2025

Mar 17, 2025·SEC

10-Q Quarterly Reports

4
FY 2026

May 6, 2026·SEC

FY 2025

Nov 10, 2025·SEC

FY 2025

Aug 7, 2025·SEC

QTRX Frequently Asked Questions

Quanterix Corporation (QTRX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Quanterix Corporation (QTRX) reported $144.9M in revenue for fiscal year 2025. This represents a 1089% increase from $12.2M in 2015.

Quanterix Corporation (QTRX) grew revenue by 2.4% over the past year. Growth has been modest.

Quanterix Corporation (QTRX) reported a net loss of $104.2M for fiscal year 2025.

Dividend & Returns

Quanterix Corporation (QTRX) has a return on equity (ROE) of -34.2%. Negative ROE indicates the company is unprofitable.

Quanterix Corporation (QTRX) had negative free cash flow of $82.9M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in QTRX back in 2015?

Total return calculator · dividends reinvested · 11+ years of data

See returns →

How much would $100/month in QTRX be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →